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Abstract
Rationale: Huntington disease (HD) is frequently first diagnosed by the appearance of motor symptoms; the
diagnosis is subsequently confirmed by the presence of expanded CAG repeats (> 35) in the HUNTINGTIN (HTT)
gene. A BACHD rat model for HD carrying the human full length mutated HTT with 97 CAG-CAA repeats has been
established recently. Behavioral phenotyping of BACHD rats will help to determine the validity of this model and its
potential use in preclinical drug discovery studies.
Objectives: The present study seeks to characterize the progressive emergence of motor, sensorimotor and
cognitive deficits in BACHD rats.
Materials and Methods: Wild type and transgenic rats were tested from 1 till 12 months of age. Motor tests were
selected to measure spontaneous locomotor activity (open field) and gait coordination. Sensorimotor gating was
assessed in acoustic startle response paradigms and recognition memory was evaluated in an object recognition
test.
Results: Transgenic rats showed hyperactivity at 1 month and hypoactivity starting at 4 months of age. Motor
coordination imbalance in a Rotarod test was present at 2 months and gait abnormalities were seen in a Catwalk test
at 12 months. Subtle sensorimotor changes were observed, whereas object recognition was unimpaired in BACHD
rats up to 12 months of age.
Conclusion: The current BACHD rat model recapitulates certain symptoms from HD patients, especially the marked
motor deficits. A subtle neuropsychological phenotype was found and further studies are needed to fully address the
sensorimotor phenotype and the potential use of BACHD rats for drug discovery purposes.
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Huntington disease (HD) is a progressive neurodegenerative
disorder that is associated with widespread degeneration of
cortical neurons and striatal medium spiny neurons (MSN)
[1–3]. The neuronal loss is caused by an expanded
polyglutamine tract (> 35 CAG) in the HUNTINGTIN (HTT)
gene on chromosome 4 [4]. Huntingtin (htt) has many functions
in cells and is essential for development [5–8]. It is not well-
known why MSN neurons are selectively vulnerable in HD [9].
A wide variety of motor, cognitive and neuropsychiatric
symptoms have been observed in HD patients [10,11]. As the
disease progresses, patients become completely dependent
and eventually require full-time care. To date, clinically proven
treatments that can cure or halt the disease’s progression have
not yet been discovered.
Important insights into the pathogenic mechanisms in HD
were gained by the development and use of multiple transgenic
murine models. At present, a number of knock-in and
transgenic mouse models, expressing the N-terminal fragment
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e68584
of HD exon 1 (e.g. R6/2 mice [12]) or the full-length
endogenous / human mutant htt (such as the BACHD mice
[13]) provide ample opportunities to study the chronically
progressing phenotype of the disease [14]. A good animal
model should reflect as many of the neuropathological and
clinical symptoms of the human disease as possible [15]. The
BACHD mouse model of HD, for example, recapitulates
several aspects of the neuropathology and symptoms,
including formation of mutant htt positive aggregates, reduction
in cortical BDNF mRNA expression levels, cognitive, emotional,
motor and sensory gating deficits [13,16–20]. Notwithstanding
the value of existing mouse HD models, certain behavioral
processes related to learning and memory and
pharmacological validation are typically more challenging to
evaluate in mice [21]. This is one of the reasons why the
availability of HD models in other species is important. Certain
aspects of the behavioral repertoire of rats are more adequate
and/or accessible for assessment in specific tasks, such as in
learning and memory models. A BACHD rat model of HD has
recently been established. This rat model is of particular
interest since it expresses, like the BACHD mouse, the full
length human mutant huntingtin (fl-mhtt) with 97 CAG-CAA mix
repeats under control of the human HD promoter gene [22].
This model has not been fully characterized yet and this was
the aim of the present studies that are described below.
We first wanted to get a detailed description of possible gait
abnormalities in BACHD rats because HD patients have motor
impairments such as gait deficits, imbalance, clumsiness and
unsteadiness [10]. In this study, we used the Catwalk, an
automated video-computer based system that detects and
measures a range of spatial and temporal aspects of rodent’s
inter-limb coordination during free walking [23]. Also, we
wanted to replicate motor imbalance reported in BACHD rats
with a Rotarod test [22,24]. The Rotarod has become an
essential tool for assessment of motor coordination and
balance in rodent models of HD [13,18,25–27]. Finally, we
employed an Actimot apparatus to evaluate exploratory
locomotor activity of BACHD rats in an open field.
The progressive degeneration of striatal MSN in HD patients
may result in deficits in sensorimotor gating inhibition. This
‘gating’ inhibition can be measured in patients by exposing
them to startle stimuli. The startle reflex response elicited by
either tactile or acoustic stimuli is typically inhibited when it is
preceded by a weak prepulse. Interestingly, Swerdlow and
colleagues [28] have reported prepulse inhibition (PPI) deficits
in HD patients. In animals, startle response and PPI can be
derived from the assessment of whole body movement
following exposure to auditory or visual stimuli [18,19,29].
Since the PPI test is of particular interest for its ‘translational’
value, we investigated the acoustic startle response (ASR) and
prepulse inhibition in BACHD rats.
Neuropsychological assessments found that, in general,
cognitive impairments start prior to the emergence of motor
deficits, although these are generally diagnosed later [30,31].
Episodic memory – that is, the memory for events which is
described as a spatio-temporal record of a subject’s experience
- is impaired in HD patients. Some of the most common tests
used to measure episodic memory are based on auditory and
verbal learning [Rey auditory verbal learning test (RAVLT),
California verbal learning test (CVLT), Wechsler memory scale
(WMS)], or pattern and spatial recognition. Results from
recognition memory performance in patients have led to mixed
results and seem to depend on the task that is used. For
example, verbal recall memory impairment was reported in the
CVLT and WMS tests [32]; whereas performance in spatial
recognition memory was intact [31]. A meta-analysis conducted
on a computer-based search in presymptomatic, symptomatic
and control subjects has revealed deficit in recall-recognition
memory in HD [33]. In addition, investigations made in a tgHD
rat model have showed spatial and recognition memory deficits
at 16 months of age [34]. Although there seems to be a clear
impairment in recall-recognition memory in HD patients and
tgHD rats, there is a further need to clarify recognition memory
performance. Therefore we evaluated the recognition memory
in BACHD rats in a novel object recognition task (ORT).
Materials and Methods
Ethics statement
The study was carried out in strict accordance with the
German animal welfare act and the EU legislation (EU directive
2010/63/EU). The protocol was approved by the local ethics
committee Behörde für Gesundheit und Verbraucherschutz
(BGV, Hamburg).
Husbandry and genotyping
Wild type (+/+, WT) and transgenic (+/T, TG) male BACHD
rats carrying the mutant human huntingtin gene, under the
control of the human huntingtin promoter and its regulatory
elements were used. The transgene contains 97 CAG-CAA mix
repeats, and additional 20 kb upstream and 50 kb downstream
sequences ensure stability of the repeat length [22]. Two
transgenic males (TG5 line) were supplied from the original
BACHD colony of the Universitätsklinikum Tübingen
(Tuebingen, Germany) and an in-house breeding colony was
established and maintained at EVOTEC AG (Hamburg,
Germany) by cross-breeding these males with wild type female
rats. BACHD animals were maintained on a Sprague-Dawley
background. All the animals at weaning were group-housed 2
to 4 per cage with wood shavings and a filter top. The
environment was enriched with a play tunnel and shredded
paper. BACHD rats were maintained in climate controlled
housing, with a 12-h reversed dark/light cycle (light from 19: 00
to 07:00). Rats had free access to food and water except
during experiments.
Ear punches were collected from the litters at weaning in
order to determine the rats genotype. Genotyping was
performed before and after all the studies using a validated
protocol. Briefly, genomic DNA was prepared from ear biopsy
tissue using proteinase K digestion, followed by phenol/
chloroform extraction (Qiagen DNeasy Tissue kit). Primers
flanking the polyQ repeat in exon 1 were designed to recognize
whether or not the rat carried at least one copy of the mutation,
and were used to PCR amplify the polyQ regions [Q3: 5’ –
AGG TCG GTG CAG AGG CTC CTC -3’ and Q5: 5’ – ATG
GCG ACC CTG GAA AAG CTG -3’]. Gene status was
Motor and Recognition Memory Assessment in HD Rats
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confirmed in parallel by using designed primers from
Tuebingen [exon 1: FW 5’-ATG GCG ACC CTG GAA AAG
CTG- 3’ and RV: 5’ -AGG TCG GTG CAG AGG CTC CTC- 3’;
exon 67: FW 5’-TGT GAT TAA TTT GGT TGT CAA GTT TT- 3’
and RV: 5’ –AGC TGG AAA CAT CAC CTA CAT AGA CT- 3’].
The PCR product was run on an automated apparatus
PTC-200 (Peltier Thermal Gradient Cycler) and the Agilent
2100 Bioanalyser (Agilent technologies) was used to determine
the fragments’ size.
Behavior testing
All the behavioral tests were performed during the dark
phase and male BACHD rats were weighed twice per month.
Acoustic startle experiments and object recognition tests were
undertaken independently on all animals of a cohort at a
specific age. For other tests, subgroups of either one or more
cohorts were allocated for longitudinal testing. Before each
behavioral test, animals were given a 1h minimum habituation
period to the testing room.
Exploratory behavior.  Spontaneous locomotor activity was
evaluated with the automated Actimot system (TSE system,
Germany). The apparatus consists of a square shape frame
equipped with a transparent cage (50 cm3) and two pairs of
light-beam strips. Each strip is equipped with 32 infrared
sensors and their height can be adjusted. Thus, the
coordinates of the animal can be determined in three
dimensions (X-Y-Z axis). The apparatus was cleaned and dried
with a 10% ethanol solution before each use. Each rat was
placed in the center of the box and the number of beam breaks
recorded during free walking for a 1 hour testing period. We
examined and analyzed the total activity (X+ Y beam breaks)
directly from the data collected by the system software.
Rotarod.  Motor coordination and balance was assessed
using a rotarod apparatus (Med Associates, Italy). All rats
underwent a 3-day training program by which time a steady
baseline level of performance was attained. During that period,
rats were trained to walk against the motion of a rotating drum
at a constant speed of 12 R.P.M (rotations per minute) for a
maximum of 2 min. In total, four training trials per day with an
interval trial time of one hour were performed. Rats falling off
during a training trial were put back on the rotating drum.
Following the training days, a one day test of three trials was
performed using an accelerating speed levels (4 to 40 R.P.M)
mode of the apparatus over 5-min. The apparatus was wiped
with a 70% ethanol solution and dried before each trial. The
mean latency to fall off the rotarod was recorded and rats
remaining on the drum for more than 300 s were removed and
their time scored as 300 s.
Catwalk system.  The gait analysis system Catwalk 7.1
(Noldus IT, the Netherlands) consisted of an enclosed walkway
with a glass plate and a speed video recording camera. Gait
performance was assessed and recorded using the catwalk
analysis software. The glass plate was cleaned and dried with
a 70% ethanol solution before each use. On the first day, rats
were habituated to the apparatus for 300 s with the goal to
cross the walkway. The following day, free runs across the
walkway were recorded. From among the correct runs, three
runs per animal were selected randomly for analysis. A correct
run was defined as one complete (60 cm) crossing of the
walkway without interruption. For one crossing, a rat needs a
minimum of 4 to 5 step sequences patterns. Runs with step
sequence categories related to exploration, Rotate Ra (RF-LF-
LF-RH) and Rotate Rb (LF-RF-RH-LH) were not analyzed (RF=
right forelimb; RH= right hindlimb; LF= left forelimb; LH= left
hindlimb).
The Catwalk parameters are: walking speed (measured as
the average of strides in cm/s); the normal step sequences
patterns (NSSP, i.e. the order in which the four paws were
placed); base-of-support (B.O.S, i.e. distance between two hind
or fore paws, as measured perpendicular to the walking
direction); stride length (i.e. distance between the placement of
a hind or fore limb and the subsequent placement of the same
limb); print position (space relation between a fore and a hind
paw of the same side in mm); regularity index [RI, i.e. an index
for the degree of interlimb coordination during gait, as
measured by the NSSP, multiplied by four (number of paws),
divided by the number of limb placements, and multiplied by
100%]; stance (i.e. time of contact of the hind or fore limbs with
the glass floor); swing (i.e. time that the hind or fore limbs are
not in contact with the glass plate); phase of dispersion [i.e. the
timing relationships between paw placements. It is expressed
as percentage of time of initial contact of one paw (the target)
related to the stride length of another paw, the anchor]; max
contact (at) (i.e. the point where the breaking phase turns into
propulsion phase); intensity (measured as the mean brightness
of all pixels of the print at maximum paw contact ranging from 0
to 255 arbitrary units).
Based on the previous study in BACHD mice [16], the
hypothesis was to investigate gait abnormalities in the rat
model with the same construct. Therefore we focused on the
same parameters we identified in the BACHD mice study.
Some of the selected parameters were: the normal step pattern
sequences, the width between forelimbs placements, stand/
propulsion time with their limbs and timing relationships
between paw placements. A full description of the apparatus,
parameters and analysis is provided by Hamers and
colleagues [23].
Object Recognition Test (ORT).  Our ORT protocol was
similar to a previously described [34]. The apparatus consisted
of a circular arena, which was 80 cm in diameter. The floor of
the arena and the 35 cm high wall was made of grey polyvinyl
chloride.
During testing periods, the experimental room was
homogenously illuminated (~ 20 lux). Two objects were placed
in a symmetrical position about 20 cm away from the wall. In
each trial the objects were placed on the exact same location.
Two different sets of objects were used, which had no natural
significance or possible association for the rats. The different
sets used were: (1) three food cans made of metal painted in
blue (diameter 7 cm, height 11 cm) (2), three metal tee caddies
cubes (8.5 cm × 8.5 cm × 11 cm, coffee background color) with
different shape and size letterings. The objects were secured to
the floor to prevent rats from displacing them. On the first day,
rats were habituated to the arena without objects for 5 min. In
the period preceding the testing, rats were adapted to the
arena and all objects 5 min/day for two days.
Motor and Recognition Memory Assessment in HD Rats
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An ORT testing session (day 4) comprised of two trials (T1
and T2) and the duration of each trial was 3 min. During T1 the
arena contained two identical objects. A rat was always placed
in the arena facing the wall. After the first exploration period
(T1) the rat was returned to its home cage. Subsequently, after
a retention interval of 90 min, the rat was put back into the
arena containing a familiar (a replicate of the object) and a
novel object (T2). The time spent exploring each object during
T1 and T2 was recorded with the help of a video tracking
system (Ethovision, Noldus). The retention interval time of 90
min was chosen to ensure a reliable recognition memory in WT
rat. Exploration of an object was defined as directing the nose
towards the object at a distance of no more than 2 cm and/or
touching the object with the nose. Sitting on or leaning on an
object was not considered as exploratory behavior. In order to
obtain reliable results in this task, sufficient exploration time of
the objects is critical. The cut-off point for sufficient exploration
time was set at 7.5 s total exploration time (both objects) per
trial. Since rodents can discriminate between objects based on
olfactory cues, the objects were thoroughly cleaned and dried
after each trial with a 10% ethanol solution. All combinations
and locations (left and right) of the objects were used in a
balanced manner in order to prevent potential bias due to
preferences for particular locations or objects.
The following variables were calculated:
• (e1) is the amount of the time (in s) spent in exploring both
identical objects (a1 and a2) during T1: e1 = a1 + a2
• (e2) is the amount of the time (in s) spent in exploring both
the familiar (a3) and new object (b) during T2: e2 = a3 + b
• d1 and d2 correspond to the ability to discriminate
between the old and new object during T2: d1 = b − a3, and
d2 = (b − a3) / e2 (which is d1 corrected for the total
exploration time during T2).
A negative d2 indicates a preference for the familiar object; a
value of zero indicates no preference, and a positive d2
indicates a preference for the novel object.
Acoustic Startle Response (ASR).  The experiments took
place in standard “Prime” isolation cabinets from San Diego
Instruments (SD Instruments, California). Each ventilated
chamber contains a loudspeaker at the top and a cylindrical
animal enclosure (10 cm diameter and 20 cm length) made
with Plexiglas and mounted on a plastic frame. A piezoelectric
accelerometer was mounted under the plastic frame to record
and transduce the motion of the tube. All chambers were
cleaned with a 70% ethanol solution and dried before each
use. Rats were individually placed in the startle enclosure and
the resulting movement of the rat was measured during 100
milliseconds (ms) after startle stimulus onset. The response
was rectified, amplified and digitized into a computer which
calculated the maximal response over the 100 ms period. All
rats were habituated for 5-min during which a 70 decibels (dB)
background white noise was present. After this habituation
period, one of three different experiments was performed
similarly to established protocols on independent cohorts
[35,36]:.
Prepulse Inhibition (PPI)
Rats underwent a test session of 51 trials consisting of:
eighteen startle pulse, twenty-four prepulse and nine no
stimulus trials where no acoustic pulses were delivered. The
startle pulse (P120) consisted of a single 120 dB [A] white
noise burst lasting 40 ms. Five pulse-alone (P120) stimuli were
presented at the beginning and at the end of the test session.
Three types of auditory prepulse at 3, 6, 12 dB above the
background noise (70 dB) were presented in random order,
followed by a single P120. Each prepulse lasted 20 ms and the
prepulse-pulse interval time was 80ms. An average of 16 s
(ranging from 10 to 20 s) separated consecutive trials and the
total session was approximately 17 min. PPI was calculated as
the percent decrease of the ASR in pulse-alone trials
compared to the ASR in prepulse-pulse trials [100× ((pulse-
alone trial) – (prepulse-pulse trial))/pulse-alone trial].
Startle Habituation
Rats were subjected to 50 startle trials with an intertrial
interval varying between 10 s and 20 s. The startle trial (P120)
consisted of a single 120 dB [A] white noise burst lasting 40
ms. Data were analyzed as mean of 10 trials in 5 blocks (BL).
Startle Threshold
Differences in ASR magnitude for different stimulus
intensities (dB) were assessed. Rats received 60 startle trials
with varying dB levels ranging from 80 to 120 dB [A] in 10-dB
increments, and a no stimulus-free trial (70 dB background
noise) per 10 trials. These stimuli lasting 40 ms were randomly
assigned to trials within each set of 10 trials. The mean
response for all trials of a given dB level, including trials for the
70 dB background white noise for each individual rat was
calculated.
Statistical Analysis.  All data are shown as the mean ±
SEM. Graph Pad and InvivoStat software were used to perform
all analyses. Differences between groups were assessed with
Student’s t-test or mix ANOVA with repeated measures, with
the factor GENOTYPE as between subject and TIME, AGE,
INTENSITY or TRIAL as within subject variable. When
significance was found, a Bonferroni - post hoc analysis was
performed where appropriate. In the ORT test, to evaluate the
preference of each genotype, we performed a one sample t-
test on the discrimination index. The hypothetical value was set
at zero. The significance level was set at 0.05.
Results
Gross inspection of each BACHD rat prior to the experiments
did not reveal any visible differences in phenotype between
wild type (WT) and transgenic (TG) animals: all animals
appeared healthy. Only male rats were used to avoid any
potential effects of changes in the female estrus cycle on
behavioral responses. For each test, dedicated cohorts and
their size are reported in Table 1.
Motor and Recognition Memory Assessment in HD Rats
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Body weight (Fig. 1a)
Both, TG and WT littermate control rats body weight
increased over time. A repeated measure ANOVA did not
reveal any significant GENOTYPE effect (F(1,276) = 2657.06,
P > 0.1), but, as expected, a significant AGE effect was found
(F(6,276) = 717.67, P < 0.001). A GENOTYPE x AGE
interaction was not found.
Locomotor activity (Fig. 1b)
In comparison to WT, TG rats showed hyperactivity at one
month of age (t= 2.978, P < 0.01) followed by hypoactivity
starting at 4 months of age (t= 4.415, P < 0.001). This
hypoactivity in TG rats persisted till 12 months of age [6
months (t= 3.586, p < 0.001), 9 months (t= 2.784, p < 0.01) and
12 months (t= 2.176, p < 0.05)]. No statistical difference
between WT and TG rats was present in 1.5, 2 and 3 months
old BACHD rats. A repeated measure ANOVA revealed
significant GENOTYPE (F(1,331) = 26.97, P <0.001), AGE
(F(7,331) = 10.54, P <0.001) and GENOTYPE x AGE (P <
0.01) effects.
Rotarod (Figure 1c-d)
Differences in latency to fall off the rotating beam between
TG and WT rats were found for training trials at constant speed
(Figure 1c, 12 r.p.m) and for testing trials at accelerating speed
(Figure 1d, 4 to 40 r.p.m); For technical reasons, results from
training at constant speed mode for 1 month old rats cannot be
presented. The 12 months old cohort could not be tested
because the animals were simply too big to stand on the beam
of the rotarod apparatus that we used. Visual inspection of
Figure 1(c-d) indicates a progressive decline in rotarod
performance for all animals during training at constant speed
and test trials at accelerating speed. In fact, TG fell off the
rotarod faster than WT rats. This motor coordination deficit and
imbalance started at 2 months of age and persisted across
time. A repeated measure ANOVA revealed significant
GENOTYPE and AGE effects [constant speed: GENOTYPE,
F(1,167) = 75.47, P < 0.001 and AGE, F(4,167) = 14.53, P <
0.001; accelerating speed: GENOTYPE, F(1,188) = 58.34, P <
0.001 and AGE, F(5,188) = 17.08, P < 0.001]. No GENOTYPE
x AGE interaction was found.
Catwalk gait analysis system (Figure 2)
We investigated gait deficits in BACHD rats with a Catwalk
system. Results from rats of 2 independent cohorts that had
made 3 good runs, aged 6 months (WT, n= 6; TG, n= 7) and 12
months (WT, n= 7; TG, n= 3) were analyzed. There was no
significant difference in general walking speed at 6 and 12
months. No significant differences in static and dynamic
parameters were observed between WT and TG rats at 6
months (data not shown). However, at 12 months, TG rats
exhibited a shorter stride length (front limbs, t= 2.194 and
p<0.05; hind limbs, t= 2.355 and P< 0.05), shorter stand (the
duration contact with the glass plate; front limbs, t= 2.107 and
p<0.05; hind limbs, t= 2.690 and P< 0.05) and shorter front
limbs swing (t= 2.871 and p< 0.01). There was a statistical
trend for a difference in hind limb swing (the duration of no
contact with the glass plate; t= 1.819 and p = 0.079). No
significant differences were found for the other parameters
(data not shown).
Object Recognition test (ORT) (Figure 3)
Three WT rats of the 4 months old group and one WT rat
from the 12 months old group were excluded from the analysis
as they did not explore the objects. Visual inspection of Figure
3a indicates that TG rats had a higher total exploration time
(e2). Indeed, during T1 and T2, significant GENOTYPE and
TIME effects were found in four months old [2-way ANOVA:
GENOTYPE, F(1,25) = 4.75, P< 0.05; TIME, F(1,25) = 9.45, P<
0.01] and 12 months old rats (GENOTYPE, F(1,18) = 4.92, P<
0.05; TIME, F(1,18) = 4.87, P< 0.05). Bonferroni post hoc
testing revealed significant differences only for (e2) exploration
time in 12 months old rats (t = 2.612, P < 0.05). No interaction
between GENOTYPE and TIME was found.
Analysis of the recognition performance during T2 (Figure
3b) revealed a TIME effect at 4 months of age [2-way ANOVA:
GENOTYPE, F(1,25) = 3.482, P> 0.05; TIME, F(1,25) = 16.62,
p< 0.001] whereas a GENOTYPE and TIME effects were found
at 12 months of age (GENOTYPE, F(1,18) = 6.589, P< 0.05;
TIME, F(1,18) = 39.34, p< 0.001). In all, WT and TG had a
significantly higher exploration time for novel objects than
familiar objects at both ages (4 months: WT, t = 2.389, P< 0.05
and TG, t = 3.444, P< 0.01; 12 months: WT, t = 4.218, P< 0.01
and TG, t = 4.735, P< 0.001).
Table 1. Summary of BACHD rat cohort sizes for each behavioral experiment.
BACHD rats AGE (months)
Behavioral tests 1 1.5 2 3 4 6 9 12
Weight (25:15)*  (29:15) (15:15) (30:20) (25:16) (27:13) (31:12)
Locomotor Activity (17:7) (16:16) (29:15) (30:20) (13:13) (37:22) (28:13) (31:12)
Catwalk      (14:15)  (14:5)
Rotarod (8:9)  (24:27) (19:18) (12:13) (15:16) (20:12)  
Object recognition     (15:15)   (14:6)
Prepulse inhibition (17:17)    (13:13)  (14:15) (28:12)
Startle habituation      (15:15)   
Startle threshold       (13:15)  
(*) indicates group size (WT: TG).
Motor and Recognition Memory Assessment in HD Rats
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The relative discrimination index (d2) was positive in both
age groups (Figure 3c). A one sample t-test revealed a
statistically significant difference from zero for both 4 months
old (WT, t = 2.8, P< 0.05; TG, t = 4.1, P< 0.01) and 12 months
old (WT, t = 5.38, P< 0,001; TG, t = 6.18, P< 0.01) rats.
Acoustic Startle Response (ASR) (Figure 4)
We evaluated sensorimotor gating in different BACHD rat
cohorts. Prepulse inhibition (PPI) was assessed in 1, 4, 9 and
12 months old rats, whereas startle habituation and startle
threshold were evaluated in 6 and 9 months old rats,
respectively. A first look to the results yields very little with
large standard errors in PPI and startle threshold (Data S1).
Given the fact that we have rigorously executed the
experiments with fairly good large size of animals per test and
time points, possible confounding factors could be attributed to
outliers. Therefore, we performed a Grubb’s test analysis and
as a result removed the outliers, which indeed significantly
reduced the variability of the groups.
Figure 1.  Phenotype.  Results are expressed as Mean ± SEM. (a) Body weight. There is no significant difference between TG and
WT control rats. (b) Locomotor activity. Compared to WT, TG rats have a higher total activity at one month followed by a lower
activity starting at 4 months of age. (c-d) Rotarod. Presented are the latency to fall off the rod during (c) constant speed (12 r.p.m)
and (d) accelerating speed (4 - 40 r.p.m). A significant difference between groups was present already at 2 months of age [constant
speed (2 months: t= 3.373, P< 0.001; 3 months: t= 3.53, P< 0.01; 4 months: t= 4.798; P< 0.001; 6 months: t=5.433; p< 0.001 and 9
months: t= 2.742, P< 0.05); accelerating speed (1 month: t= 1.066, P> 0. 1; 2 months: t= 4.172, P< 0.001; 3 months: t= 3.549, P<
0.01; 4 months: t= 6.493, p< 0.001; 6 months: t= 4.263, P< 0.001 and 9 months: t= 3.015, P< 0.01)]. Asterisks indicate significant
differences between WT and TG rats (*p < 0.05; **p < 0.01 and ***p < 0.001).
doi: 10.1371/journal.pone.0068584.g001
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Prepulse Inhibition (PPI) (Figure 4a)
For the PPI experiments, prepulse intensities (PP) of 3, 6, 12
dB above background were used. One month old (17WT:
16TG), 4 months old (12WT:13TG), 9 months old (13WT:
14TG) and 12 months old (25WT:11TG) BACHD rats data
were analyzed. A 2-way ANOVA analysis with GENOTYPE as
a between subjects factor and TRIAL (PP3, PP6, PP12) as a
within subjects factor revealed a significant GENOTYPE and
TRIAL effect in 9 months old rats [GENOTYPE: (F(2,25) =
5.42, P< 0.05; TRIAL: F(2,50) = 12.96, P< 0.0001) with PP6, t
= 2.78, P< 0.05 and PP12, t= 2.76, P< 0.05 Bonferroni post
hoc test)]. An interaction between GENOTYPE and TRIAL was
detected (F(2,50)= 4.589, P< 0.05). No significant GENOTYPE
effect was found at 1, 4 and 12 months of age; however a
significant TRIAL effect was detected in all groups [(1 month,
F(2,62)= 65.02, P< 0.0001; 4 months, F(2,46)= 53.14, P<
0.0001 and 12 months, F(2,68)= 41.27, P< 0.0001)]. There was
no interaction between GENOTYPE and TRIAL. A close
inspection of the data for the 1 month old rats suggests a
difference between WT and TG rats at PP6 and PP12. A post
hoc analysis of 1 month old rats revealed a trend to
significance at PP12 (PP6, t = 2.026, P = 0.136; PP12, t =
2.206 and P = 0.089). This suggests that 1 month old
transgenic rats have mildly impaired sensorimotor gating.
Together with 4 and 12 months old rats from Figure 4 data, the
deficits were too subtle to reveal a significant, overall, genotype
difference between WT and TG rats at any of the other
prepulse intensities following post hoc analysis. Finally,
analysis of startle amplitude on P120 alone trials in BACHD
rats did not show differences between groups (data not
shown).
Startle Habituation (Fig. 4b)
To further evaluate startle habituation in BACHD rats, six
months old rats were presented 50 trials of a 120 dB (P120)
startle stimulus. The results are presented in 5 blocks of 10
trials. Visual inspection of Figure 4b suggests a general
decrease in startle amplitude. This was confirmed by a 2-way
ANOVA with a significant TRIAL effect (F(4,112) = 3.36, P<
0.05). However, no statistically significant GENOTYPE effect or
GENOTYPE and TRIAL interaction was found.
Startle Threshold (Figure 4c)
We evaluated 9 months old BACHD rat’s response
magnitude to different stimulus intensities; five startle
intensities (80dB to 120 dB), 10 trials each, were presented.
Ten WT and 12 TG BACHD rats’ data were analyzed. WT and
TG startle amplitude increased with the startle stimulus
intensity. A 2-way ANOVA analysis revealed a significant
INTENSITY effect at 120 dB [INTENSITY, F(5,100) = 26.80, P<
0.0001 and 120 dB, t = 2.965 and P < 0.05]. However, there
was no over-all GENOTYPE effect and no interaction between
GENOTYPE and INTENSITY was found.
Figure 2.  Catwalk gait analysis in 12 months old BACHD rats.  Results are expressed as Mean ± SEM. There was no
significant difference between TG and WT control rats in walking speed (data not shown). (a) Static parameters: Stride length.
Compared to WT, TG rats had a significant shorter stride length for both front and hind paws during walking. (b-c) Dynamic
parameters: presented are the Stand (c) and the Swing (d). TG rats had a significant shorter time of stand (or Stance) for front and
hind paws and a shorter time in front swing than WT rats. Asterisks indicate significant differences between WT and TG rats (*p <
0.05 and **p < 0.01).
doi: 10.1371/journal.pone.0068584.g002
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Discussion
We evaluated transgenic BACHD rats and wild type
littermate control in a series of standard behavioral tests
assessing motor, sensory-motor and cognitive function. TG rats
showed a clear motor coordination imbalance on a Rotarod, as
well as gait coordination deficits in both static and dynamic free
walking sequences as measured with a catwalk system. These
data demonstrate a progressive motor impairment over time as
seen in patients. Rats showed intact recognition memory as
measured in an object recognition test. A clear deficit in
sensory-motor paradigms (startle habituation, and startle
threshold) was absent, although a subtle impairment in PPI
was found. Whereas we confirmed the motor phenotype as
described previously [22], we expected a more profound
cognitive and sensorimotor phenotype. Additional studies will
be needed to provide further insights into the validity of the
BACHD rat model for HD and how this model compares with
other rodent models for HD.
Motor Behavior
The first clinical reports on HD predominantly addressed
motor symptoms, including progressive involuntary movements
named “chorea” [37]. Therefore, we started first with the
assessment of motor behavior in our comprehensive
behavioral phenotyping approach of BACHD rats.
A first report on ambulatory activity in BACHD rats found
hypoactivity at 3 months of age [22]. In the present study, TG
rats showed hyperactivity in an open field environment at 1
month followed by a progressive and long-lasting hypoactivity
starting at 4 months. Similar observations have been reported
in YAC 128 mice with a hyperkinetic phenotype at 3 months
followed by hypokinetic phenotype at 6 months of age [38].
However, results from other rodent models for HD have been
variable. For example, hyperactivity was found in transgenic
tgHD rats carrying 51 CAG-repeats, with higher exploratory
distance travelled in an open field test at 6, 7, 8 and 10 months.
A progressive hypoactivity phenotype was found in transgenic
BACHD mice, starting at 7 months [18,39].
The hyperactivity detected in BACHD rats at an early age (4
weeks) was only expressed for a very short time window as it
had disappeared at 6 weeks. Yu-Taeger and colleagues have
probably missed this phenotype in BACHD rats as they started
testing at 3 months of age. However, the robustness of this
phenotype needs to be addressed in follow-up studies with a
higher number of animals (there were only 7 rats in the one
month old transgenic cohort). Nevertheless, it is encouraging
that the biphasic activity pattern in our rats appears to mimic
more closely some of the clinical neuropsychiatric symptoms
reported in pre-manifest and manifest HD patients [40,41].
Measurement of motor coordination and balance on a
rotarod showed a clear deficit in TG rats as they have a shorter
latency to fall off the rotating rod during constant speed training
trials and during accelerating speed trials. It is interesting to
note that the performance of WT rats on the rotarod declines
over time. Indeed, weight gain in rats can impact rotarod
Figure 3.  Object Recognition Test (ORT).  Results are expressed as Mean ± SEM. Three WT rats of the 4 months old group and
one WT rat from the 12 months old group were excluded from the analysis as they did not explore the objects (a) Exploration time
(e1) and (e2) during T1 and T2 respectively. TG rats showed a significantly higher exploration time during e2 at 12 months of age.
(b) Recognition testing during T2: 4 months and 12 months old BACHD rats had a significantly higher exploration time to the novel
object than the familiar object. (c) The discrimination index (d2) for both groups are above zero and were significant at each age.
Asterisks indicate statistical significance (*p < 0.05; **p < 0.01 and ***p < 0.001).
doi: 10.1371/journal.pone.0068584.g003
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performance; however the results demonstrate that the
difference we observed between WT and TG BACHD rats is
unlikely to be influenced by animal’s weight. The same
observations were made by Yu-Taeger and colleagues [22],
with TG rats having difficulties maintaining balance on the rod
at higher rotation speeds. The progressive imbalance in rats
persists over time and is consistent with data obtained from
BACHD mice and tgHD rats [13,16–19,26,42]. Taken together,
these data prove the reliability of using the Rotarod test for
motor coordination assessment across laboratories.
Gait abnormalities were found in both static and dynamic
parameters during Catwalk testing in 12 months old rats. TG
rats had a shorter stride length and decreased stand duration
of front and hind paws. A decrease in swing duration was
observed for the front paws. Although velocity can significantly
influence catwalk gait parameters [43], the deficits in BACHD
rats are unlikely to be confounded by this parameter as TG and
WT rats did not differ in walking speed. Footprints of TG rats
have been previously investigated for gait abnormality at 14
months of age. Shorter steps for limbs, increased stride width
and reduced overlap between forelimbs and hindlimbs
Figure 4.  Startle testing.  Results are expressed as Mean ± SEM. (a) Prepulse inhibition. A 2 way-ANOVA revealed a
GENOTYPE difference in 9 months old BACHD rats especially at PP 6 and PP 12; however any significant differences were found
in 1, 4 and 12 months old rats. (b) Startle habituation amplitude in 6 months old rats. Each trial consisted of 10 blocks of 120 dB
startle stimuli. WT and TG rats presented a normal startle habituation. (c) Startle threshold. Amplitude to varying startling stimulus
intensities in 9 months old rats. WT and TG response amplitude increased with higher stimulus intensities. No GENOTYPE effect
was observed. However, a significant difference was detected at 120 dB. Asterisks indicate statistical significance in BACHD rats
(*p < 0.05).
doi: 10.1371/journal.pone.0068584.g004
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placement were found [22]. In accordance with our findings,
similar results have been reported in other HD rodent models.
For example, tgHD rats also showed decreases in stand and
swing duration in a Catwalk test [44]. R6/2 transgenic mice
displayed a significantly shorter stride length by 8-9 weeks of
age in an ink-footprint test, and shorter stance time for front
and hind limbs at 17 weeks in a Digigait system during
treadmill locomotion [25,45]. Finally, HD patients show gait
abnormalities like mean decrease in velocity, stride length and
cadence [46].
Based on the early and profound coordination deficits in the
Rotarod, we did not expect the late occurrence of relative mild
gait abnormalities in TG rats. However, consistent with the late
onset in BACHD rats, we found gait abnormalities at an
advanced age (10 months) in BACHD mice such as:
differences in the NSSP cruciate and alternate, larger distance
between forelimbs placements, shorter stand/propulsion time
with their hindlimbs and timing relationships between paw
placements [16]. However, none of these deficits were found in
12 months old BACHD rats in the present study.
Methodological confounds cannot be excluded but seem
unlikely as the mice and rats were tested in the same
laboratory, by the same experimenter, using the same
equipment. This illustrates that the disease progression in 2
different species with a same construct might be different.
Although gait deficits appear to be present at 14 months of age
with the footprints test, it would be worthwhile investigating if
major deficits in Catwalk performance are present in BACHD
rats that are older than 12 months.
Object recognition
Recognition memory was investigated in BACHD rats in an
ORT task and intact object memory was found in 4 and 12
months old rats. A close look at the recognition performance of
12 months old rats during T2 suggests a better cognitive
performance in TG rats. Unfortunately, the design of the
experiments (i.e. using a relatively short inter trial interval) was
aimed at inducing a robust object recognition in WT rats. One
way to investigate the hypothesis that TG rats actually have
superior performance would be to increase the inter trial time
between T1 and T2 and observe if WT rats performance
decrease faster. This would, however, be beyond the scope of
this study, which was signed to investigate only whether TG
rats have reduced recognition memory. Given that both
transgenic and control groups exhibit a significant positive
discrimination index, we can conclude that their recognition
memory is intact. Our results contrast with findings in another
rat model for HD. tgHD rats show deficits in ORT and OLT
(object location test) at 16 months of age [34] and cognitive
deficits have been reported as early as 9 months of age with
different tasks assessing visual-spatial learning and memory
processing [47–49]. It cannot be ruled out that we might have
missed a recognition memory deficit as BACHD rats show no
clear htt aggregates or neurodegeneration before 12 months of
age [22]. Therefore, we assume that in contrast to motor
behavior, the circuitry involved in ORT may become
dysfunctional only if htt aggregates have formed. Further
studies need to be done in animals and humans to better
understand if and how object memory is impaired in HD. Object
memory seems to be impaired in HD patients. In a pattern
recognition task (a task similar to the rat ORT), subjects had to
remember and touch the abstract patterns they were shown
during training and that were paired with a novel pattern during
testing. Early HD patients and clinically symptomatic subjects
performed significantly worse than control subjects [50,51],
whereas in at-risk gene carriers, no difference in recognition
memory was found [31]. Irrespectively, this is the first study to
report intact object memory in BACHD rat and further studies in
older cohorts may shed further light on a potential recognition
memory deficit.
Acoustic Startle Response
Nine months old BACHD transgenic rats had a significant
prepulse inhibition deficit at 6 and 12 dB prepulse (PP)
intensities. Closer inspection of 1 month old rats’ data suggests
subtle deficits at PP 6 and 12 dB. However, no genotype
differences were found in 1, 4 and 12 months old rats.
Likewise, no statistical difference was detected in startle
responding and startle habituation.
PPI deficits have been demonstrated in BACHD mice and
YAC 128 mice models for HD at later ages [18,19,52]. Impaired
PPI has been shown in the neurotoxic rat model after systemic
administration of 3-Nitropropionic acid [53,54]. Also, PPI has
been extensively investigated in several neuropsychiatric
disorders [55–57]. In HD patients, only Swerdlow and
colleagues [28] have reported reduced PPI in both acoustic
and tactile startle reflex whereas no impairment was observed
in startle amplitude, habituation or prepulse latency facilitation
paradigms. In view of 1) the correlations between PPI
impairments and degenerative changes in the striatum of
animal models and HD patients; and 2) the absence of clear
neurodegeneration or striatal htt aggregates in caudate
putamen (CPu) before 12 months of age [22], it cannot be ruled
out that a PPI deficit develops after 12 months of age.
Unfortunately, we could not test older rats since they were too
big for the standard PPI rat enclosures. Although this technical
issue is certainly not insurmountable, an interesting alternative
would be to test PPI in a non-human primate model for HD
[58]. Testing in a different species would help to shed more
light on the robustness of a sensorimotor gating deficit in HD
models.
Conclusion
In the present time course study, we investigated motor,
sensorimotor and cognitive symptoms in BACHD rats.
Transgenic rats showed motor coordination imbalance on a
Rotarod and subtle gait deficits in a Catwalk system. These
rats had an intact object recognition memory and a subtle
deficit in prepulse inhibition of acoustic startle. In contrast to the
symptoms progression in patients, BACHD rats may not show
object memory impairment until after motor deficits occurred.
Further assessment of other cognitive functions, such as
reversal learning and associative memory, may shed further
light on the comparative time courses for the emergence of
motor and cognitive deficits.
Motor and Recognition Memory Assessment in HD Rats
PLOS ONE | www.plosone.org 10 July 2013 | Volume 8 | Issue 7 | e68584
If deficits in sensorimotor and cognition functions are linked
to htt aggregation, it is possible that our BACHD rats were too
young (12 months) to show robust deficits. Yu-Taeger and
colleagues [22] revealed that nuclear accumulation of N-
terminal htt appeared in cortex after 9 months of age and few
aggregates were present in the dorsolateral caudate putamen
from 12 months old rats and increases thereafter. However, the
relationship between mutant huntingtin (mhtt) aggregation and
MSN loss, motor and cognitive deficits in BACHD rodent
models for HD appears complex. Sometimes symptoms occur
before the neuropathology like in BACHD mice, where few mhtt
aggregates are present at 12 months of age in cortical and
striatal regions [13,17,19,20]. Further studies need to be
performed to better understand the molecular and cellular
mechanisms underpinning motor and cognitive symptoms in
BACHD rats.
Supporting Information
Data S1.  Startle testing.  Results are expressed as Mean ±
SEM. (a) Prepulse inhibition and (b) Startle threshold amplitude
in BACHD rats. 2 way ANOVA: Prepulse inhibition
[GENOTYPE: (1 month, F (1,32) = 3.84, P = 0.0587; 4 months,
F (1,24)= 0.376, P= 0.545; 9 months F (1,27)= 1.447, P= 0.23
and 12 months, F (1,38)= 0.311, P= 0.58); TRIAL: (1 month, F
(2,64) = 68.22, P = 0.0492 with PP 12, t= 2.438 P= 0.0498 ; 4
months, F (2,48)= 10.74, P= 0.0001, 9 months F (2,54)= 13.22,
P> 0.0001 and 12 months, F (2,76)= 16.25, P> 0.0001) ];
Startle threshold [9 months, GENOTYPE: F (1.26) = 2.109, P=
0.158); INTENSITY: F(5,130)= 23.73, P> 0.0001 with 120 dB, t
= 3.473 and P = 0.004]. The general observation of data
indicated that no statistical differences in over all GENOTYPE
might potentially be due to some outliers. The results without
outliers are presented in figure 4.
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